Clinical Textbook of Addictive Disorders 3rd ed - R. Frances, S. Miller, A. Mack (Guilford, 2005) WW

12. Co-Occurring Substance Use Disorders and Other Psychiatric Disorders 301treatment of adult ADHD patients with comorbid cocaine dependence. Exp ClinPsychopharmacol, 10(3), 286–294.Schweizer, E., Rickels, K., & Lucki, I. (1986). Resistance to the anti-anxiety effect ofbuspirone in patients with a history of benzodiazepine use. N Engl J Med, 314, 719–720.Shaner, A., Khalsa, M. E., Roberts, L., Wilkins, J., Anglin, D., & Hsieh, S. C. (1993).Unrecognized cocaine use among schizophrenic patients. Am J Psychiatry, 150,758–762.Sigmon, S. C., Steingard, S., Badger, G. J., Anthony, S. L., & Higgins, S. T. (2000).Contingent reinforcement of marijuana abstinence among individuals with seriousmental illness: A feasibility study. Exp Clin Psychopharmacol, 8(4), 509–517.Smelson, D. A., Losonczy, M. F., Davis, C. W., Kaune, M., Williams, J., & Ziedonis, D.(2002). Risperdone decreases craving and relapses in individuals with schizophreniaand cocaine dependence. Can J Psychiatry, 47, 671–675.Smelson, D. A., Losonczy, M. F., Kilker, C., Starosta, A., Kind, J., Williams, J., &Ziedonis, D. (2002). An analysis of cue reactivity among persons with and withoutschizophrenia who are addicted to cocaine. Psychiatr Serv, 53, 1612–1616.Sonne, S. C., & Brady, K. T. (2000). Naltrexone for individuals with comorbid bipolardisorder and alcohol dependence. J Clin Psychopharmacol, 20, 114–115.Spencer, C., Castle, D., & Michie, P. T. (2002). Motivations that maintain substanceuse among individuals with psychotic disorders. Schizophr Bull, 28, 233–247.Substance Abuse and Mental Health Services Administration. (2002). Report to Congresson the prevention and treatment of co-occurring substance abuse disorders and mentaldisorders. Washington, DC: Authors.Swanson, A. J., Pantalon, M. V., & Cohen, K. R. (1999). Motivational interviewingand treatment adherence among psychiatric and dually diagnosed patients. J NervMent Dis, 187, 630–635.Tollefson, G. D., Montague-Clouse, J., & Tollefson, S. L. (1992). Treatment of comorbidgeneralized anxiety in a recently detoxified alcoholic population with a selectiveserotonergic drug (buspirone). J Clin Pharmacol, 12, 19–26.Upadhyaya, H. P., Brady, K. T., Sethuraman, G., Sonne, S. C., & Malcolm, R. (2001).Venlafaxine treatment of patients with comorbid alcohol/cocaine abuse andattention-deficit/hyperactivity disorder: A pilot study. J Clin Psychopharmacol, 21,116–117.Velasquez, M. M., Carbonari, J. P., & DiClemente, C. C. (1999). Psychiatric severity andbehavior change in alcoholism: The relation of the transtheoretical model variablesto psychiatric distress in dually diagnosed patients. Addict Behav, 24, 481–496.Weiss, R. D. (1986). Psychopathology in chronic cocaine abusers. Am J Drug AlcoholAbuse, 12, 17–29.Weiss, R. D. (1992a). Drug abuse as self-medication for depression: An empirical study.Am J Drug Alcohol Abuse, 18, 121–129.Weiss, R. D. (1992b). The role of psychopathology in the transition from drug use toabuse and dependence. In M. Glantz & R. Pickens (Eds.), Vulnerability to drugabuse (pp. 137–148). Washington, DC: American Psychological Association.Weiss, R. D. (1998). Validity of substance use self-reports in dually diagnosed outpatients.Am J Psychiatry, 155, 127–128.